Neonatal Platelet Transfusions and Future Areas of Research

Transfusion Medicine Reviews

Volumn 30, Issue 4, 2016, Pages 183-188

  Sola Visner, Martha ^a   Bercovitz, Rachel S ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

Infant, newborn; Infant, premature; Platelet transfusion; Sepsis; Thrombocytopenia

Indexed keywords

ANGIOGENESIS; CHRONIC LUNG DISEASE; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; DISEASE EXACERBATION; HEMOSTASIS; HIGH RISK PATIENT; HUMAN; NECROTIZING ENTEROCOLITIS; NEONATAL THROMBOCYTOPENIA; NEWBORN CARE; NONHUMAN; PHOTOCHEMISTRY; RETROLENTAL FIBROPLASIA; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION; SEPSIS; THERAPY EFFECT; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE TRANSFUSION; TREATMENT OUTCOME; TREATMENT PLANNING; VIRUS TRANSMISSION; BLEEDING; BLOOD TRANSFUSION; HEMATOLOGY; NEONATAL INTENSIVE CARE UNIT; NEOVASCULARIZATION (PATHOLOGY); NEWBORN; PLATELET COUNT; PREMATURITY; PROCEDURES; THROMBOCYTE; THROMBOCYTOPENIA; TRENDS;

BLOOD PLATELETS; BLOOD TRANSFUSION; HEMATOLOGY; HEMORRHAGE; HEMOSTASIS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE UNITS, NEONATAL; NEOVASCULARIZATION, PATHOLOGIC; PLATELET COUNT; PLATELET TRANSFUSION; RISK FACTORS; THROMBOCYTOPENIA;

EID: 84971659803     PISSN: 08877963     EISSN: 15329496     Source Type: Journal    
DOI: 10.1016/j.tmrv.2016.05.009     Document Type: Review

References (68)

1. [1] Burrows, RF, Kelton, JG, Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med 329 (1993), 1463–1466.
2. [2] Andrew, M, Castle, V, Saigal, S, Carter, C, Kelton, JG, Clinical impact of neonatal thrombocytopenia. J Pediatr 110 (1987), 457–464.
3. [3] Castle, V, Andrew, M, Kelton, J, Giron, D, Johnston, M, Carter, C, Frequency and mechanism of neonatal thrombocytopenia. J Pediatr 108 (1986), 749–755.
4. [4] Mehta, P, Vasa, R, Neumann, L, Karpatkin, M, Thrombocytopenia in the high-risk infant. J Pediatr 97 (1980), 791–794.
5. [5] Christensen, RD, Henry, E, Wiedmeier, SE, Stoddard, RA, Sola-Visner, MC, Lambert, DK, et al. Thrombocytopenia among extremely low birth weight neonates: data from a multihospital healthcare system. J Perinatol 26 (2006), 348–353.
6. [6] Wiedmeier, SE, Henry, E, Sola-Visner, MC, Christensen, RD, Platelet reference ranges for neonates, defined using data from over 47,000 patients in a multihospital healthcare system. J Perinatol 29 (2009), 130–136.
7. [7] Andrew, M, Vegh, P, Caco, C, Kirpalani, H, Jefferies, A, Ohlsson, A, et al. A randomized, controlled trial of platelet transfusions in thrombocytopenic premature infants. J Pediatr 123 (1993), 285–291.
8. [8] Lieberman, L, Bercovitz, RS, Sholapur, NS, Heddle, NM, Stanworth, SJ, Arnold, DM, Platelet transfusions for critically ill patients with thrombocytopenia. Blood 123 (2014), 1146–1151 [quiz 280].
9. [9] Josephson, CD, Su, LL, Christensen, RD, Hillyer, CD, Castillejo, MI, Emory, MR, et al. Platelet transfusion practices among neonatologists in the United States and Canada: results of a survey. Pediatrics 123 (2009), 278–285.
10. [10] Cremer, M, Sola-Visner, M, Roll, S, Josephson, CD, Yilmaz, Z, Buhrer, C, et al. Platelet transfusions in neonates: practices in the United States vary significantly from those in Austria, Germany, and Switzerland. Transfusion 51 (2011), 2634–2641.
11. [11] Stanworth, SJ, Clarke, P, Watts, T, Ballard, S, Choo, L, Morris, T, et al. Prospective, observational study of outcomes in neonates with severe thrombocytopenia. Pediatrics 124 (2009), e826–e834.
12. [12] Sparger, KA, Assmann, SF, Granger, S, Winston, A, Christensen, RD, Josephson, C, et al. Platelet transfusion practices among very low birth weight infants. JAMA Pediatr, 2016 [Published online May 23, 2016.
13. [13] Garcia, MG, Duenas, E, Sola, MC, Hutson, AD, Theriaque, D, Christensen, RD, Epidemiologic and outcome studies of patients who received platelet transfusions in the neonatal intensive care unit. J Perinatol 21 (2001), 415–420.
14. [14] Curley, A, Venkatesh, V, Stanworth, S, Clarke, P, Watts, T, New, H, et al. Platelets for neonatal transfusion—study 2: a randomised controlled trial to compare two different platelet count thresholds for prophylactic platelet transfusion to preterm neonates. Neonatology 106 (2014), 102–106.
15. [15] Carr, R, Kelly, AM, Williamson, LM, Neonatal thrombocytopenia and platelet transfusion—a Uk perspective. Neonatology 107 (2015), 1–7.
16. [16] Muthukumar, P, Venkatesh, V, Curley, A, Kahan, BC, Choo, L, Ballard, S, et al. Severe thrombocytopenia and patterns of bleeding in neonates: results from a prospective observational study and implications for use of platelet transfusions. Transfus Med 22 (2012), 338–343.
17. [17] Baer, VL, Lambert, DK, Henry, E, Christensen, RD, Severe thrombocytopenia in the nicu. Pediatrics 124 (2009), e1095–e1100.
18. [18] von Lindern, JS, van den Bruele, T, Lopriore, E, Walther, FJ, Thrombocytopenia in neonates and the risk of intraventricular hemorrhage: a retrospective cohort study. BMC Pediatr, 11, 2011, 16.
19. [19] Israels, SJ, Rand, ML, Michelson, AD, Neonatal platelet function. Semin Thromb Hemost 29 (2003), 363–372.
20. [20] Sitaru, AG, Holzhauer, S, Speer, CP, Singer, D, Obergfell, A, Walter, U, et al. Neonatal platelets from cord blood and peripheral blood. Platelets 16 (2005), 203–210.
21. [21] Andrew, M, Paes, B, Bowker, J, Vegh, P, Evaluation of an automated bleeding time device in the newborn. Am J Hematol 35 (1990), 275–277.
22. [22] Boudewijns, M, Raes, M, Peeters, V, Mewis, A, Cartuyvels, R, Magerman, K, et al. Evaluation of platelet function on cord blood in 80 healthy term neonates using the platelet function analyser (pfa-100); shorter in vitro bleeding times in neonates than adults. Eur J Pediatr 162 (2003), 212–213.
23. [23] Israels, SJ, Cheang, T, McMillan-Ward, EM, Cheang, M, Evaluation of primary hemostasis in neonates with a new in vitro platelet function analyzer. J Pediatr 138 (2001), 116–119.
24. [24] Shenkman, B, Linder, N, Savion, N, Tamarin, I, Dardik, R, Kennet, G, et al. Increased neonatal platelet deposition on subendothelium under flow conditions: the role of plasma von willebrand factor. Pediatr Res 45 (1999), 270–275.
25. [25] Ucar, T, Gurman, C, Arsan, S, Kemahli, S, Platelet aggregation in term and preterm newborns. Pediatr Hematol Oncol 22 (2005), 139–145.
26. [26] Linder, N, Shenkman, B, Levin, E, Sirota, L, Vishne, TH, Tamarin, I, et al. Deposition of whole blood platelets on extracellular matrix under flow conditions in preterm infants. Arch Dis Child Fetal Neonatal Ed 86 (2002), F127–F130.
27. [27] Levy-Shraga, Y, Maayan-Metzger, A, Lubetsky, A, Shenkman, B, Kuint, J, Martinowitz, U, et al. Platelet function of newborns as tested by cone and plate(let) analyzer correlates with gestational age. Acta Haematol 115 (2006), 152–156.
28. [28] Del Vecchio, A, Latini, G, Henry, E, Christensen, RD, Template bleeding times of 240 neonates born at 24 to 41 weeks gestation. J Perinatol 28 (2008), 427–431.
29. [29] Bednarek, FJ, Bean, S, Barnard, MR, Frelinger, AL, Michelson, AD, The platelet hyporeactivity of extremely low birth weight neonates is age-dependent. Thromb Res 124 (2009), 42–45.
30. [30] Kundu, SK, Heilmann, EJ, Sio, R, Garcia, C, Davidson, RM, Ostgaard, RA, Description of an in vitro platelet function analyzer—PFA-100. Semin Thromb Hemost 21:Suppl. 2 (1995), 106–112.
31. [31] Deschmann, E, Sola-Visner, M, Saxonhouse, MA, Primary hemostasis in neonates with thrombocytopenia. J Pediatr 164 (2014), 167–172.
32. [32] Kaiser-Guignard, J, Canellini, G, Lion, N, Abonnenc, M, Osselaer, JC, Tissot, JD, The clinical and biological impact of new pathogen inactivation technologies on platelet concentrates. Blood Rev 28 (2014), 235–241.
33. [33] Wollowitz, S, Fundamentals of the psoralen-based helinx technology for inactivation of infectious pathogens and leukocytes in platelets and plasma. Semin Hematol 38 (2001), 4–11.
34. [34] Ciaravino, V, Hanover, J, Lin, L, Sullivan, T, Corash, L, Assessment of safety in neonates for transfusion of platelets and plasma prepared with amotosalen photochemical pathogen inactivation treatment by a 1-month intravenous toxicity study in neonatal rats. Transfusion 49 (2009), 985–994.
35. [35] http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/PremarketApprovalsPMAs/ucm427488.htm, 2014 [Accessed: 2/2/2016].
36. [36] Reesink, HW, Panzer, S, McQuilten, ZK, Wood, EM, Marks, DC, Wendel, S, et al. Pathogen inactivation of platelet concentrates. Vox Sang 99 (2010), 85–95.
37. [37] Knutson, F, Osselaer, J, Pierelli, L, Lozano, M, Cid, J, Tardivel, R, et al. A prospective, active haemovigilance study with combined cohort analysis of 19,175 transfusions of platelet components prepared with amotosalen-uva photochemical treatment. Vox Sang 109 (2015), 343–352.
38. [38] Irsch, J, Lin, L, Pathogen inactivation of platelet and plasma blood components for transfusion using the intercept blood system. Transfus Med Hemother 38 (2011), 19–31.
39. [39] Osselaer, JC, Messe, N, Hervig, T, Bueno, J, Castro, E, Espinosa, A, et al. A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment. Transfusion 48 (2008), 1061–1071.
40. [40] Rasongles, P, Angelini-Tibert, MF, Simon, P, Currie, C, Isola, H, Kientz, D, et al. Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a chikungunya virus epidemic in ile de la Reunion. Transfusion 49 (2009), 1083–1091.
41. [41] Bowden, RA, Slichter, SJ, Sayers, M, Weisdorf, D, Cays, M, Schoch, G, et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 86 (1995), 3598–3603.
42. [42] Nash, T, Hoffmann, S, Butch, S, Davenport, R, Cooling, L, Safety of leukoreduced, cytomegalovirus (CMV)-untested components in CMV-negative allogeneic human progenitor cell transplant recipients. Transfusion 52 (2012), 2270–2272.
43. [43] Josephson, CD, Caliendo, AM, Easley, KA, Knezevic, A, Shenvi, N, Hinkes, MT, et al. Blood transfusion and breast milk transmission of cytomegalovirus in very low-birth-weight infants: a prospective cohort study. JAMA Pediatr 168 (2014), 1054–1062.
44. [44] Menter, DG, Tucker, SC, Kopetz, S, Sood, AK, Crissman, JD, Honn, KV, Platelets and cancer: a casual or causal relationship: revisited. Cancer Metastasis Rev 33 (2014), 231–269.
45. [45] von Lindern, JS, Hulzebos, CV, Bos, AF, Brand, A, Walther, FJ, Lopriore, E, Thrombocytopaenia and intraventricular haemorrhage in very premature infants: a tale of two cities. Arch Dis Child Fetal Neonatal Ed 97 (2012), F348–F352.
46. [46] Ballabh, P, Intraventricular hemorrhage in premature infants: mechanism of disease. Pediatr Res 67 (2010), 1–8.
47. [47] Ballabh, P, Xu, H, Hu, F, Braun, A, Smith, K, Rivera, A, et al. Angiogenic inhibition reduces germinal matrix hemorrhage. Nat Med 13 (2007), 477–485.
48. [48] Ment, LR, Stewart, WB, Fronc, R, Seashore, C, Mahooti, S, Scaramuzzino, D, et al. Vascular endothelial growth factor mediates reactive angiogenesis in the postnatal developing brain. Brain Res Dev Brain Res 100 (1997), 52–61.
49. [49] Cognasse, F, Boussoulade, F, Chavarin, P, Acquart, S, Fabrigli, P, Lamy, B, et al. Release of potential immunomodulatory factors during platelet storage. Transfusion 46 (2006), 1184–1189.
50. [50] Kanter, J, Khan, SY, Kelher, M, Gore, L, Silliman, CC, Oncogenic and angiogenic growth factors accumulate during routine storage of apheresis platelet concentrates. Clin Cancer Res 14 (2008), 3942–3947.
51. [51] International Committee for the Classification of Retinopathy of Prematurity, The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 123 (2005), 991–999.
52. [52] Jensen, AK, Ying, GS, Huang, J, Karp, K, Quinn, GE, Binenbaum, G, Thrombocytopenia and retinopathy of prematurity. J AAPOS 15 (2011), e3–e4.
53. [53] Vinekar, A, Hegde, K, Gilbert, C, Braganza, S, Pradeep, M, Shetty, R, et al. Do platelets have a role in the pathogenesis of aggressive posterior retinopathy of prematurity?. Retina 30 (2010), S20–S23.
54. [54] Arif, SH, Ahmad, I, Ali, SM, Khan, HM, Thrombocytopenia and bacterial sepsis in neonates. Indian J Hematol Blood Transfus 28 (2012), 147–151.
55. [55] Bonifacio, L, Petrova, A, Nanjundaswamy, S, Mehta, R, Thrombocytopenia related neonatal outcome in preterms. Indian J Pediatr 74 (2007), 269–274.
56. [56] Bolat, F, Kilic, SC, Oflaz, MB, Gulhan, E, Kaya, A, Guven, AS, et al. The prevalence and outcomes of thrombocytopenia in a neonatal intensive care unit: a three-year report. Pediatr Hematol Oncol 29 (2012), 710–720.
57. [57] Levit, O, Bhandari, V, Li, FY, Shabanova, V, Gallagher, PG, Bizzarro, MJ, Clinical and laboratory factors that predict death in very low birth weight infants presenting with late-onset sepsis. Pediatr Infect Dis J 33 (2014), 143–146.
58. [58] Liu, ZJ, Hoffmeister, KM, Hu, Z, Mager, DE, Ait-Oudhia, S, Debrincat, MA, et al. Expansion of the neonatal platelet mass is achieved via an extension of platelet lifespan. Blood 123 (2014), 3381–3389.
59. [59] Khashu, M, Osiovich, H, Henry, D, Al Khotani, A, Solimano, A, Speert, DP, Persistent bacteremia and severe thrombocytopenia caused by coagulase-negative staphylococcus in a neonatal intensive care unit. Pediatrics 117 (2006), 340–348.
60. [60] Stanworth, SJ, Thrombocytopenia, bleeding, and use of platelet transfusions in sick neonates. Hematology Am Soc Hematol Educ Program 2012 (2012), 512–516.
61. [61] Stolla, M, Refaai, MA, Heal, JM, Spinelli, SL, Garraud, O, Phipps, RP, et al. Platelet transfusion—the new immunology of an old therapy. Front Immunol, 6, 2015, 28.
62. [62] McFadyen, JD, Kaplan, ZS, Platelets are not just for clots. Transfus Med Rev 29 (2015), 110–119.
63. [63] de Stoppelaar, SF, van ‘t Veer, C, Claushuis, TA, Albersen, BJ, Roelofs, JJ, van der Poll, T, Thrombocytopenia impairs host defense in gram-negative pneumonia-derived sepsis in mice. Blood 124 (2014), 3781–3790.
64. [64] van den Boogaard, FE, Schouten, M, de Stoppelaar, SF, Roelofs, JJ, Brands, X, Schultz, MJ, et al. Thrombocytopenia impairs host defense during murine streptococcus pneumoniae pneumonia. Crit Care Med 43 (2015), e75–e83.
65. [65] Wuescher, LM, Takashima, A, Worth, RG, A novel conditional platelet depletion mouse model reveals the importance of platelets in protection against Staphylococcus aureus bacteremia. J Thromb Haemost 13 (2015), 303–313.
66. [66] Caudrillier, A, Kessenbrock, K, Gilliss, BM, Nguyen, JX, Marques, MB, Monestier, M, et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest 122 (2012), 2661–2671.
67. [67] Hwaiz, R, Rahman, M, Syk, I, Zhang, E, Thorlacius, H, Rac1-dependent secretion of platelet-derived ccl5 regulates neutrophil recruitment via activation of alveolar macrophages in septic lung injury. J Leukoc Biol, 2015.
68. [68] Guo, Y, Mishra, A, Howland, E, Zhao, C, Shukla, D, Weng, T, et al. Platelet-derived wnt antagonist dickkopf-1 is implicated in ICAM-1/VCAM-1–mediated neutrophilic acute lung inflammation. Blood 126 (2015), 2220–2229.